Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Wipf

Showing results (291-300 of 430) with videos related to

Pageof 43
Sort By:
Molecular Cancer Therapeutics|September 20, 2005
The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non-small cell lung cancer xenograftsNathan T Ihle, Gillian Paine-Murrieta, Margareta I Berggren, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 21, 2013
Evaluation of a novel calcium channel agonist for therapeutic potential in Lambert-Eaton myasthenic syndromeTyler B Tarr, Waqas Malick, Mary Liang, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 17, 2009
Identifying a resistance determinant for the antimitotic natural products disorazole C1 and A1John S Lazo, Celeste E Reese, Andreas Vogt, et al.
Annals of the New York Academy of Sciences|November 11, 2017
Lambert-Eaton myasthenic syndrome: mouse passive-transfer model illuminates disease pathology and facilitates testing therapeutic leadsStephen D Meriney, Tyler B Tarr, Kristine S Ojala, et al.
Epigenetics|October 10, 2019
PTPRT epigenetic silencing defines lung cancer with STAT3 activation and can direct STAT3 targeted therapiesMalabika Sen, Audrey Kindsfather, Ludmila Danilova, et al.
Neurourology and Urodynamics|May 29, 2018
Relaxin-2 therapy reverses radiation-induced fibrosis and restores bladder function in miceYouko Ikeda, Irina V Zabbarova, Lori A Birder, et al.
Antiviral Research|August 18, 2012
A screen for modulators of large T antigen's ATPase activity uncovers novel inhibitors of Simian Virus 40 and BK virus replicationSandlin P Seguin, Alex W Ireland, Tushar Gupta, et al.
Journal of Molecular and Cellular Cardiology|December 3, 2014
Mitochondria-targeted ROS scavenger improves post-ischemic recovery of cardiac function and attenuates mitochondrial abnormalities in aged ratsNelson Escobales, Rebeca E Nuñez, Sehwan Jang, et al.
Molecular Pharmacology|August 24, 2017
<i>N</i>-Acetyl-l-Cysteine Protects Astrocytes against Proteotoxicity without Recourse to GlutathioneAmanda M Gleixner, Daniel F Hutchison, Sara Sannino, et al.
Journal of Cell Science|August 23, 2018
Compensatory increases of select proteostasis networks after Hsp70 inhibition in cancer cellsSara Sannino, Christopher J Guerriero, Amit J Sabnis, et al.
Pageof 43

Showing results (291-300 of 430) with videos related to

Sort By:
Pageof 43
Molecular Cancer Therapeutics|September 20, 2005
The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non-small cell lung cancer xenograftsNathan T Ihle, Gillian Paine-Murrieta, Margareta I Berggren, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 21, 2013
Evaluation of a novel calcium channel agonist for therapeutic potential in Lambert-Eaton myasthenic syndromeTyler B Tarr, Waqas Malick, Mary Liang, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 17, 2009
Identifying a resistance determinant for the antimitotic natural products disorazole C1 and A1John S Lazo, Celeste E Reese, Andreas Vogt, et al.
Annals of the New York Academy of Sciences|November 11, 2017
Lambert-Eaton myasthenic syndrome: mouse passive-transfer model illuminates disease pathology and facilitates testing therapeutic leadsStephen D Meriney, Tyler B Tarr, Kristine S Ojala, et al.
Epigenetics|October 10, 2019
PTPRT epigenetic silencing defines lung cancer with STAT3 activation and can direct STAT3 targeted therapiesMalabika Sen, Audrey Kindsfather, Ludmila Danilova, et al.
Neurourology and Urodynamics|May 29, 2018
Relaxin-2 therapy reverses radiation-induced fibrosis and restores bladder function in miceYouko Ikeda, Irina V Zabbarova, Lori A Birder, et al.
Antiviral Research|August 18, 2012
A screen for modulators of large T antigen's ATPase activity uncovers novel inhibitors of Simian Virus 40 and BK virus replicationSandlin P Seguin, Alex W Ireland, Tushar Gupta, et al.
Journal of Molecular and Cellular Cardiology|December 3, 2014
Mitochondria-targeted ROS scavenger improves post-ischemic recovery of cardiac function and attenuates mitochondrial abnormalities in aged ratsNelson Escobales, Rebeca E Nuñez, Sehwan Jang, et al.
Molecular Pharmacology|August 24, 2017
<i>N</i>-Acetyl-l-Cysteine Protects Astrocytes against Proteotoxicity without Recourse to GlutathioneAmanda M Gleixner, Daniel F Hutchison, Sara Sannino, et al.
Journal of Cell Science|August 23, 2018
Compensatory increases of select proteostasis networks after Hsp70 inhibition in cancer cellsSara Sannino, Christopher J Guerriero, Amit J Sabnis, et al.
Pageof 43